The “Extreme Exercise Hypothesis”: Recent Findings and Cardiovascular Health Implications
Purpose of review
The “Extreme Exercise Hypothesis” is characterized by a U-shaped or reverse J-shaped, dose-response curve between physical activity volumes and cardiovascular health outcomes. In this review, we summarize recent findings that may support or refute the “Extreme Exercise Hypothesis.” Furthermore, we discuss potential cardiovascular health implications of the cardiac anatomical, structural, contractility, and biomarker abnormalities that have been reported in some veteran endurance athletes.
Emerging evidence from epidemiological studies and observations in cohorts of endurance athletes suggest that potentially adverse cardiovascular manifestations may occur following high-volume and/or high-intensity long-term exercise training, which may attenuate the health benefits of a physically active lifestyle. Accelerated coronary artery calcification, exercise-induced cardiac biomarker release, myocardial fibrosis, atrial fibrillation, and even higher risk of sudden cardiac death have been reported in athletes.
There is primarily circumstantial evidence that supports the “Extreme Exercise Hypothesis.” Subclinical and atherosclerotic coronary artery disease (CAD) as well as structural cardiovascular abnormalities and arrhythmias are present in some of the most active veteran endurance athletes and need appropriate clinical follow-up to reduce the risk for adverse cardiovascular outcomes. Future studies are warranted to establish the long-term cardiovascular health effects of these findings in veteran endurance athletes.
KeywordsEndurance exercise Atherosclerosis Myocardial fibrosis Sudden cardiac death Physical activity Athletes
The World Health Organization (WHO) recommends that adults aged 18–64 engage in at least 150 min/week of moderate intensity aerobic activities or 75 min/week of vigorous intensity aerobic activities or an equivalent combination thereof . Furthermore, complementary muscle-strengthening activities should be performed involving major muscle groups on two or more days a week. Regular aerobic exercise and resistance training are associated with a reduced risk for cardiovascular morbidity [2, 3] and mortality [4, 5]. The dose-response relationship between aerobic exercise volumes, which largely reflect the duration and intensity of physical activity, and the associated health benefits is most often described as curvilinear, with the greatest exercise-induced health improvements at the beginning of the curve . Nevertheless, the WHO recommends that more exercise is better, and it is estimated that maximal cardiovascular health benefits are obtained at an exercise volume that approximates up to ~ 3 to 4 times the current exercise recommendations [7, 8].
Confirmation or rejection of the “Extreme Exercise Hypothesis” is a hot topic in the field of sports cardiology. There are valid concerns that the message that high-volume, high-intensity exercise can potentially harm the heart, may discourage a physically active lifestyle among the general population and contribute to the increasing prevalence of physical inactivity. The aims of this review are to (1) summarize recent findings that support or refute the “Extreme Exercise Hypothesis” and (2) interpret the potential effects of exercise-induced (mal)adaptations on cardiovascular health outcomes.
Identification of a potential upper limit
Few studies had sufficient power to explore the dose-response relationship between physical activity and cardiovascular health outcomes, which allows identification of a potential upper limit. Arem et al. combined leisure-time physical activity data from six prospective population-based cohorts from the USA and Europe to create a study population of 661,137 individuals [9••]. Maximal risk reduction for all-cause mortality occurred at an exercise volume of 3 to 5 times current exercise recommendations (hazard ratio [HR]: 0.61, 95% confidence interval [CI]: 0.59–0.62). Individuals performing physical activity at a volume ≥ 10 times current exercise recommendations had a lower mortality risk (HR: 0.69, 95% CI: 0.59–0.78) compared to the inactive reference group, but health benefits in the most active group were smaller compared to the optimal exercise volume group (31% vs. 39% risk reduction). Lear et al. more recently analyzed a cohort of 130,843 individuals from 17 low- to high-income countries to explore the effect of physical activity on mortality and cardiovascular disease (CVD) . Individuals in the high physical activity group had a substantially reduced risk for all-cause mortality (HR: 0.65, 95% CI: 0.68–0.77) and major CVD (HR: 0.75, 95% CI: 0.69–0.82) compared to the low physical activity group. Recreational physical activity at ~ 112 min/week yielded the largest risk reductions for the combined endpoint of mortality and major CVD (HR: 0.89, 95% CI: 0.82–0.95), but these significant health benefits were lost at physical activity volumes above 255 min/week. These observations challenge the notion that more exercise is invariably better. However, it remains difficult to differentiate between (1) a real finding that supports the “Extreme Exercise Hypothesis” and (2) a loss of health benefits due to statistical factors produced by the relatively small number of individuals in the most active group. This possibility is supported by the large confidence intervals for the risk estimates. Based on limited current evidence and numerous potential confounders, it is difficult to delineate an upper limit for the benefits of physical activity at this time. Future studies should combine data from large cohorts, including highly active amateur athletes to determine the health effects of the highest volumes of physical activity.
Accelerated coronary artery calcification
Imaging techniques to assess underlying atherosclerotic CAD and/or myocardial fibrosis in endurance athletes
Coronary artery atherosclerosis
Coronary artery calcification (CAC) score
Transvenous endomyocardial biopsy—picrosirius red or Masson staining
Fibrillar collagen quantification
CT coronary angiography
Plaque characteristics (i.e., plaque phenotype, plaque volume)
Cardiac MRI with gadolinium contrast infusion
Presence and volume of focal myocardial fibrosis
Atherosclerotic burden and plaque characteristics
Cardiac MRI with T1 mapping
Presence and volume of diffuse myocardial fibrosis
Plaque lipid content, macrophage infiltration and thickness of fibrous cap
Recent studies have provided important novel insights regarding this widely cited observation. Aengevaeren et al. examined the association between lifelong volumes of physical activity and the prevalence and characteristics of coronary atherosclerosis in 284 male amateur athletes [21••]. The most active athletes routinely exercised at volumes equal to four times current recommendations, whereas the least active athletes exercised at the current recommended volume. The most active athletes had a higher CAC prevalence than the least active athletes (68% versus 43%, odds ratio [OR]: 3.2, 95% CI: 1.6–6.6). However, the most active athletes also had a lower prevalence of mixed plaques (48% versus 69%; OR: 0.35, 95% CI: 0.15–0.85) and more often had only calcified plaques (38% versus 16%; OR = 3.57; 95% CI: 1.28–9.97) compared with the least active athletes. This observation has important clinical relevance as mixed plaques are associated with a higher probability of future cardiovascular events compared with calcified plaques (38% versus 6%) . Similar findings were reported in an English cohort of 152 veteran athletes and 92 sedentary controls [23••]. Male athletes more often had atherosclerotic plaques (44% versus 22%; p = 0.009) and a higher prevalence of CAC > 300 (11% versus 0%, p = 0.009) compared to age and risk factor-matched sedentary controls. Again, veteran athletes predominantly had calcified plaques, whereas mixed plaques were more prevalent among controls. In aggregate, these data suggest that long-term exercise training is associated with accelerated coronary artery atherosclerosis, but that accelerated plaque calcification may outweigh the cardiovascular risks associated with increased CAC scores. Additional longitudinal studies are needed to confirm this hypothesis.
Lin et al. assessed changes in plaque characteristics among eight participants of the Race Across the USA (140 race days covering 3080 miles) . Four runners had no evidence of CAD on CT angiography before or after the race, but luminal stenosis and plaque volume (range: 4.8–94 mm3) increased in four runners with coronary atherosclerosis present before the race. The change in plaque volume was mainly attributed to an increase in non-calcified plaque. However, concomitant increases in high sensitivity C reactive protein (CRP) were noted, suggesting that exercise-induced inflammation may contribute to accelerated plaque progression. Whether initial increases in non-calcified plaque volume may change to calcified volume during race recovery is unknown. Previous studies demonstrated that exercise increased parathyroid hormone , decreased vitamin D3  and decreased magnesium levels , all biomarkers of calcium-phosphate metabolism, which could affect vascular calcification . Future studies investigating the underlying mechanisms of accelerated coronary artery atherosclerosis in veteran athletes are needed and may provide insight into how to improve strategies to stabilize plaques in vulnerable patient populations.
Increased myocardial fibrosis
Exercise-induced increases in cardiac biomarkers, such as troponin, a marker of cardiomyocyte damage, and B-type natriuretic peptide (BNP), a marker of myocardial stress, are common in athletes after endurance exercise . Recent studies explored the impact of endurance exercise on novel cardiac biomarkers, such as galectin-3, a marker of myocardial fibrosis,  and soluble suppression of tumorigenicity-2 (sST2), a marker of extracellular matrix remodeling and fibrosis . Resting levels of galectin-3 were higher in athletes (n = 21) compared to controls (n = 21), whereas significant increases were observed following a 30-km run (12.8 ± 3.4 to 19.9 ± 3.9 ng/ml, p < 0.001) . Similarly, sST2 concentrations increased following a marathon (34.2 to 54.2 ng/ml, p < 0.001), with 68 of 79 athletes (86%) demonstrating a concentration above the upper reference limit. Complete normalization of sST2 levels occurred within 48 h . Increases in cardiac biomarkers are modest and transient, but the clinical implications of these elevations are unknown. Accordingly, long-term exercise training/competition with repetitive exposure to prolonged vigorous exercise may increase cardiac fibrosis.
Cardiomyocyte damage leads to myocardial fibrosis, which is characterized by collagen infiltration in the extracellular matrix. The presence and magnitude of myocardial fibrosis can be determined via microscopic analysis of cardiac muscle obtained by postmortem biopsy or via cardiac magnetic resonance imaging (MRI; Table 1). Previous studies using MRI in athletes reported that the prevalence of myocardial fibrosis varied substantially (0% to 50%) between study populations [13, 32]. A systematic review found evidence of myocardial fibrosis in 30 of 509 scanned athletes (5.9%) [33•]. Myocardial fibrosis patterns were heterogeneous, and most frequently located near the interventricular septum and the right ventricular insertion points. The presence of myocardial fibrosis was strongly associated with the cumulative exercise dose. In contrast to studies from Germany  and the USA . Bohm et al. found no difference in left and right ventricular function parameters between 33 competitive elite male master endurance athletes and 33 controls matched for age, height, and weight, , and myocardial fibrosis was observed in only 1 athlete. Abdullah et al. compared left ventricular characteristics across groups of long-term exercisers (< 2/2–3/4–5/6–7 exercise sessions/week) and found a stepwise improvement of cardiac structure and function with increasing doses of physical activity . Among the 92 study participants, delayed gadolinium enhancement was observed in only 1 exerciser in the 2–3 sessions/week group. These studies suggest that myocardial fibrosis is a rare finding among endurance athletes. The discrepancy in prevalence rates may be due to the age and training status of the study population or to survival bias. On the other hand, Wilson et al. used delayed gadolinium enhancement on cardiovascular MRI to describe diverse patterns of myocardial fibrosis in 6 of 12 highly trained veteran endurance athletes . Additional prospective studies are needed to confirm the association between exercise dose and incident myocardial fibrosis.
Whereas previous studies predominantly employed gadolinium infusion to determine focal fibrosis, T1 mapping is increasingly used to quantitate diffuse fibrosis (Table 1). Gormeli et al. found that athletes had significantly higher left ventricular (LV) native T1 values (1230 ± 39 ms versus 1174 ± 36 ms, p < 0.001) and interventricular septum (IVS) native T1 values (1268 ± 48 ms versus 1180 ± 27 ms, p < 0.001) compared to matched sedentary controls . Furthermore, native T1 values of the LV (p < 0.05) and IVS (p < 0.05) were significantly higher in athletes that trained ≥ 5 years as compared to those training < 5 years, and the highest values of LV end diastolic volume and IVS wall thickness were found in those athletes who had trained the longest. These data suggest that more training results in greater cardiac remodeling, but potentially also more diffuse myocardial fibrosis.
The clinical consequences of myocardial fibrosis in athletes are largely unexplored. A German study found that coronary revascularization was more common in athletes with, than without, fibrosis, 25% versus 1%, respectively . Schnell et al. reported a case series of serious cardiac complications in Belgian athletes with isolated subepicardial fibrosis, such as non-sustained ventricular arrhythmias, symptomatic ventricular tachycardia, and progressive LV dysfunction . British veteran athletes with myocardial fibrosis demonstrated normal cardiac function, but co-localized regional cardiac dysfunction was found in fibrotic areas, substantiated by evidence of an attenuated cardiac strain and base to apex gradient . These observations suggest that the presence of myocardial fibrosis requires appropriate clinical follow-up to evaluate the possibility of future adverse cardiovascular outcomes.
Exercise and atrial fibrillation
On the other hand, for the general population, increased CRF is associated with a reduced risk of AF [39, 40]. There is also at least one non-randomized study demonstrating that increases in CRF achieved by a physician-led exercise program reduces the recurrence of AF in obese patients , even when weight loss is minimal . These findings suggest that the relationship between physical activity and incident AF is best summarized by a reverse J-shaped curve. Light-to-moderate amounts of exercise decrease, but larger volumes of exercise potentially increasing the risk of AF .
Sudden cardiac death
High-intensity exercise can acutely, albeit transiently, increase the risk for sudden cardiac arrest (SCA) or sudden cardiac death (SCD) in individuals with underlying cardiac disease . The cause of death is usually different for young (≤ 40 years) versus older athletes (> 40 years). Young individuals die during exercise primarily from inherited or congenital cardiac conditions, such as hypertrophic cardiomyopathy (HCM), coronary artery anomalies, and right ventricular cardiomyopathy (RVCM) , whereas atherosclerotic coronary artery disease (ASCAD) is the primary cause of death in older athletes . A Canadian study of athletic participants aged 12–45 years old found 74 cases with SCA over the course of 18.5 million persons-years of observation, yielding an incidence of 0.76 cases per 100,000 athletes per year [54••]. A total of 16 SCA cases occurred during competitive sports of which 44% survived, whereas 58 cases occurred during non-competitive sports of which 44% also survived. More importantly, genetic structural abnormalities, such as HCM and RVCM were uncommon causes of SCA (8% and 5%, respectively). This is in contrast to some primarily older studies, which identified HCM as the predominant cause of SCD in young athletes . Early risk identification of gene carriers for conditions, such as HCM and RVCM and subsequent exercise restriction, may have contributed to the apparent change in the cause of SCD in young athletes . Another study from Australia and New Zealand found a similar incidence of SCD (1.3 cases per 100,000 persons/year) in children and young adults , but included all deaths and not just exercise-related deaths. SCD incidence rate increased with age and was highest for individuals aged 31–35 years (3.2 cases per 100,000 persons/year). The Australian study reported that most SCD cases occurred during sleep (28%) and rest (20%) and relatively few cases occurred during light physical activity (14%), exercise (8%), or post-exercise (3%) . However, the investigators did not correct SCD incidence for exposure time, which precludes an accurate assessment of the relative risks of exercise. Since most people spend more time asleep than in physical activity, the 25% incidence of SCD during all intensities of exercise suggest that exercise increases the risk of SCD compared to non-exercise activities. Nonetheless, the exercise-induced risk for SCA and SCD is only transient, and there is strong evidence that regular exercise training is associated with an overall decreased risk of adverse cardiovascular outcomes [57•].
Recent studies demonstrated that extreme volumes and/or intensities of long-term exercise training are associated with several possible cardiac maladaptations. First, some epidemiological studies have reported an increased risk for adverse cardiovascular outcomes at the upper end of the physical activity spectrum. Nevertheless, there is no clear threshold for an upper limit of the exercise-induced health benefits. Second, the most active older athletes often demonstrate a higher coronary artery calcification score, but atherosclerotic plaques are more likely calcified which reduces the risk of plaque rupture. The associated cardiovascular risk implications of these observations are currently unknown. Third, elevations of biomarkers for cardiomyocyte damage and myocardial fibrosis are common following intense exercise but normalize soon after exercise cessation. Focal and diffuse fibrosis is found in a small subgroup of veteran athletes, but again, the significance of this finding is unknown. Fourth, a reversed J-shaped association is found between exercise volumes and atrial fibrillation, with a reduced risk at light-to-moderate volumes and an increased risk at high volumes. Fifth, SCA and SCD are infrequent among exercising young individuals, with an estimated incidence rate of 0.76 per 100,000 person years. Collectively, these data suggest: (1) there is limited evidence that supports the “Extreme exercise hypothesis,” the most compelling relating to the increased risk of atrial fibrillation at high volumes of exercise; (2) cardiac anomalies may be present in a small proportion of the most active veteran athletes; and (3) the combination of high-intensity physical activity in the presence of known or occult CVD, seems to be the major cause of exercise-related fatalities.
Compliance with Ethical Standards
Conflict of Interest
Thijs M.H. Eijsvogels and Barry A. Franklin each declare no potential conflicts of interest.
Paul D. Thompson reports being a member of the Speakers’ Bureau for Regeneron, Sanofi, Amgen and Amarin; serving as a consultant for Amgen, Regeneron, Esperion and Sanolfi; receiving research support from Sanofi, Regeneron, Esperion, Amgen, and Amarin; owning stock in Abbvie, Abbott, CVS, General Electric, Johnson & Johnson, Medtronic, and Sarepta; and providing legal consultation on exercise-related cardiac events and statin myopathy.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.WHO. Global Recommendations on Physical Activity for Health. http://www.who.int/dietphysicalactivity/factsheet_adults/en/ accessed at December 10th 2017.
- 9.•• Arem H, Moore SC, Patel A, et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Intern Med. 2015;175:959–67. A pooled cohort study that performed comprehensive assessment of the dose-response association between exercise and (cardiovascular) endpoints.CrossRefPubMedPubMedCentralGoogle Scholar
- 14.• Mohlenkamp S, Lehmann N, Breuckmann F, et al. Running: the risk of coronary events: Prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J. 2008;29:1903–10. Landmark study for the development of the “Extreme Exercise hypothesis.” This German study assessed coronary artery calcification scores and prevalence of myocardial fibrosis in marathon runners.CrossRefPubMedGoogle Scholar
- 21.•• Aengevaeren VL, Mosterd A, Braber TL, et al. Relationship between lifelong exercise volume and coronary atherosclerosis in athletes. Circulation. 2017;136:138–48. This study is the first to assess the dose-response relationship between lifelong physical activity volume and characterstics of coronary artery atherosclerosis in a cohort of 284 amateur athletes.CrossRefPubMedGoogle Scholar
- 23.•• Merghani A, Maestrini V, Rosmini S, et al. Prevalence of subclinical coronary artery disease in masters endurance athletes with a low atherosclerotic risk profile. Circulation. 2017;136:126–37. The authors performed a comprehensive comparison of cardiovascular structure and function, including characteristics of coronary atery atherosclerosis, between amateur athletes and sedentary controls.CrossRefPubMedGoogle Scholar
- 33.• van de Schoor FR, Aengevaeren VL, Hopman MT, et al. Myocardial fibrosis in athletes. Mayo Clinic Proc. 2016;91:1617–31. Review paper that summarizes the indicence of myocardial fibrosis among athletic populations. Furthermore, diffuse vs. focal patterns, underlying mechanisms and clinical implications of myocardial fibrosis in athletes are discussed.CrossRefGoogle Scholar
- 42.•• Andersen K, Farahmand B, Ahlbom A, et al. Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J. 2013;34:3624–31. Important study in Swedish amateur athletes, demonstrating that cardiac arrhythmias were more prevalent in faster athletes and those that had a higher number of completed races.CrossRefPubMedGoogle Scholar
- 43.Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2009;11:1156–9.CrossRefGoogle Scholar
- 51.Thompson PD, Franklin BA, Balady GJ, et al. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation. 2007;115:2358–68.CrossRefPubMedGoogle Scholar
- 54.•• Landry CH, Allan KS, Connelly KA, et al. Sudden cardiac arrest during participation in competitive sports. N Engl J Med. 2017;377:1943–53. Large retrospective study to determine the prevalence of exercise-induced sudden cardiac arrest among Canadian amateur athletes aged 12 – 45 years.CrossRefPubMedPubMedCentralGoogle Scholar
- 55.Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e273–80.CrossRefPubMedGoogle Scholar
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.